SCHEMBL4609865

SCHEMBL4609865

CCc1c(OC)ccc(S(N)(=O)=O)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.43
CA12 O43570 4/20 0.42
CA2 P00918 4/20 0.42
CA9 Q16790 4/20 0.42
CA1 P00915 3/20 0.42
ALDH1A1 P00352 5/20 0.39
CA4 P22748 1/20 0.38
PDIA6 Q15084 1/20 0.37
POLB P06746 1/20 0.37
BRD4 O60885 1/20 0.36
CA14 Q9ULX7 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4204762 0.86 PKM (0.47) PKMCA12CA2CA9CA1
SCHEMBL691733 0.80 ALDH1A1 (0.56) PKMCA12CA2CA9CA1
SCHEMBL4609359 0.80 PKM (0.43) PKMCA12CA2CA9CA1
SCHEMBL3705401 0.78 CA2 (0.47) PKMCA12CA2CA9CA1
SCHEMBL4608472 0.77 PKM (0.46) PKMCA12CA2CA9CA1
SCHEMBL18261775 0.77 PKM (0.36) PKMCA12CA2CA9CA1
Hydrochloric Acid SCHEMBL4609743 0.76 PKM (0.45) PKMCA12CA2CA9CA1
SCHEMBL13067436 0.76 ACHE (0.39) PKMCA12CA2CA9CA1
SCHEMBL18261777 0.74 PKM (0.36) PKMCA12CA2CA9CA1
SCHEMBL20549321 0.74 ALDH1A1 (0.49) PKMCA12CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976498-A2 CHEMICAL COMPOUNDS SmithKline Beecham Corporation (US) 2008-10-08 EP disclosed
WO-2007127505-A2 USE OF SULFONAMIDE DERIVATIVES IN THE TREATMENT OF DISORDERS OF THE METABOLISM AND THE NERVOUS SYSTEM SMITHKLINE BEECHAM CORPORATION (US) 2007-11-08 WO disclosed